Apollo Endosurgery, Inc. (APEN)
Chart Events
Performance Outlook
| Previous Close | 5.39 |
| Open | 5.39 |
| Bid | 5.50 x 1000 |
| Ask | 5.52 x 900 |
| Day's Range | 5.28 - 5.52 |
| 52 Week Range | 1.25 - 7.96 |
| Volume | 53,367 |
| Avg. Volume | 932,188 |
| Market Cap | 142.911M |
| Beta (5Y Monthly) | 2.35 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.99 |
| Earnings Date | Feb 25, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 9.50 |
Fair Value
Related Research
- Simply Wall St.
Estimating The Fair Value Of Apollo Endosurgery, Inc. (NASDAQ:APEN)
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Apollo Endosurgery...
- ACCESSWIRE
Apollo Endosurgery Announces Inducement Grant
AUSTIN, TX / ACCESSWIRE / March 19, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced the terms of equity awards granted to Chas McKhann in connection with his appointment as the company's CEO in March 2021.
- ACCESSWIRE
Apollo Endosurgery announces AMA assignment of Category I CPT Codes for use in Intragastric Balloon Procedures
AUSTIN, TX / ACCESSWIRE / March 8, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced the assignment of Category I Current Procedural Terminology (CPT®) codes with short form descriptor esophagogastroduodenoscopy with deployment of gastric bariatric device (e.
